332-25-2N#Cc1ccc(OC(F)(F)F)cc1XWHIXOMWXCHJPP-UHFFFAOYSA-N332-25-2DTXSID5073163Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H302 (95.7%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 47 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Uses4-(Trifluoromethoxy)benzonitrile features both cyano and trifluoromethoxy groups as electron-withdrawing substituents, establishing an acceptor–π–acceptor (A–π–A) electronic system[3]. The compound serves as a precursor for fluorophosgene, undergoing quantitative photocatalytic cleavage by an organic photosensitizer to yield benzonitrile and fluorophosgene via single-electron reduction[4]. It is also employed in the synthesis of N-benzyl benzamidine libraries through reaction with variously substituted benzyl amines[5].
General Description4-(Trifluoromethoxy)benzonitrile serves as an intermediate in the synthesis of fluvoxamine.